£
Donate

We're here for you if you want to talk

0808 2080 888

[email protected]

Building the foundations

This section of our 2022-2023 annual report covers our new CEO, our new office, and our working culture. Having worked remotely since the start of the pandemic, this year we identified a need for a smaller, more flexible and collaborative working space and are now leasing part of the Royal College of Paediatrics and Child Health premises.

Our new CEO

CEO Helen Rowntree

We said goodbye to our chief executive, Gemma Peters, who left us to become the chief executive of Macmillan Cancer Support. Following an objective process where we interviewed a strong group of candidates involving both internal and external candidates, we appointed Helen Rowntree, our director of research, services and engagement, as our new chief executive.

We believe Helen’s appointment sends a strong signal about the high quality of our staff and the importance we place on developing our staff’s careers.

Digital transformation

We have started looking at how we build our digital skills and ensure we are making the best use of data to inform our decisions. And while one of our greatest strengths is the extent to which our community is involved in our decision-making, we want to go further, and make sure the people we are involving are genuinely representative of the blood cancer community.

Alice sitting in chair

Our culture

We are proud that our latest staff survey shows that 98% of our staff say they would recommend Blood Cancer UK as a place to work, and 100% are proud to say they work here. We made progress on making Blood Cancer UK a more inclusive place to work, which is crucial for ensuring we become more representative of the blood cancer community as a whole.

Over the last year, we have rolled out a series of training sessions and a mentoring scheme with Disability Connect to help ensure we are supporting members of staff with disabilities.

We also put on sessions about menstruation and started providing free period products in our offices.

Lastly, we hosted a learning session with a guest speaker from ACLT (African Caribbean Leukaemia Trust) to help improve our staff’s understanding of the experience of people from ethnic minority groups.

Discover the rest of our 2022-2023 annual report